Research Article
Relation of Perceived Stigma to Adverse Events of Medications in Patients with Epilepsy
Table 1
Clinical findings of study participants.
| Clinical findings | | (%) | SE |
| Type of epilepsy | | | | Partial | 99 | 64.7 | 3.88 | Generalized | 54 | 35.3 | 3.88 | Type of seizures | | | | (1) Partial | | | | Simple partial | 2 | 1.3 | — | Complex partial | 10 | 6.5 | 2.01 | Partial with secondary generalization | 34 | 22.2 | 3.37 | (2) Generalized | | | | Generalized tonic-clonic | 52 | 34.0 | 3.84 | (3) Polymorphic | 55 | 36.0 | 3.89 | Etiology of epilepsy | | | | Idiopathic | 46 | 30.0 | 3.72 | Cryptogenic | 55 | 36.0 | 3.89 | Symptomatic | 52 | 34.0 | 3.84 | Recent seizure frequency | | | | No seizures in recent years | 46 | 30.1 | 3.72 | Low (1 seizure/year or 1–11 seizures/year) | 21 | 13.7 | 2.79 | High (per month, per week, or daily) | 86 | 56.2 | 4.02 | Treatment | | | | Monotherapy | 54 | 35.3 | 3.88 | polytherapy | 99 | 64.7 | 3.88 | Adverse events (AEs) | | | | No | 61 | 39.9 | 3.97 | Yes | 92 | 60.1 | 3.97 |
|
|